Clinical Trial Update: Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD) [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating octreotide injections to prevent gastrointestinal bleeding in patients with an LVAD has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Bleeding

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Gastrointestinal Bleeding | Phase 1 | Status: COMPLETED | Results posted: 2016-01-12